Glenn Schulman

Glenn Schulman

Plus aucun poste en cours
Health Technology
Consumer Services

Profil

Glenn Schulman, formerly the Director of Investor Relations at CuraGen Corp., Investor Relations Contact at Achillion Pharmaceuticals, Inc., Senior VP of Communications & Investor Relations at Aurinia Pharmaceuticals, Inc., VP of Investor Relations & Corporate Communications at X4 Pharmaceuticals, Inc., Senior Vice President of Investor Relations at ProKidney Corp., and VP and Head of Investor Relations & Communications at IN8bio, Inc., has a graduate degree from Yale University, an undergraduate degree from Philadelphia College of Pharmacy, and a doctorate from Ernest Mario School of Pharmacy.

Anciens postes connus de Glenn Schulman

SociétésPosteFin
IN8BIO, INC. Investor Relations Contact -
PROKIDNEY CORP. Investor Relations Contact -
X4 PHARMACEUTICALS, INC. Investor Relations Contact -
AURINIA PHARMACEUTICALS INC. Investor Relations Contact 15/07/2022
ACHILLION PHARMACEUTICALS, INC. Public Communications Contact -
Voir l'expérience en détail de Glenn Schulman

Formation de Glenn Schulman

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés liées

Entreprise privées9

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Glenn Schulman
🔇